Your Location:
Home >
Browse articles >
Mechanism of Zuoguiwan in Inhibiting Osteoclast Activation Induced by Breast Cancer via Regulating p38 MAPK/ERK Signaling Pathway
Updated:2024-12-17
Mechanism of Zuoguiwan in Inhibiting Osteoclast Activation Induced by Breast Cancer via Regulating p38 MAPK/ERK Signaling Pathway
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 1, Pages: 1-9(2025)
DOI: 10.13422/j.cnki.syfjx.20241822
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 6 ) Tabs( 9 )
References
Publication Info
Metrics
347
Views
340
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Anti-metastatic Effect of Zuoguiwan on Breast Cancer Cells and Its Mechanisms of Action
Traditional Chinese Medicine Regulates Related Signaling Pathways to Prevent and Control Breast Cancer and Precancerous Lesions: A Review
Exploring Mechanism of Breast Cancer Prevention by Liuwei Dihuangwan, Erzhiwan and Zuoguiwan Based on Macrophage Phagocytosis
Clinical and Mechanistic Research Progress on Classical Traditional Chinese Medicine Formulas in Treatment of Chronic Heart Failure
Effect and Mechanism of Modified Sini San on Improving Intestinal Mucosal Barrier of Chronic Stress Rats via Regulating Short-chain Fatty Acid Metabolism and Inhibiting HMGB1/RAGE Signaling Pathway
Related Author
ZOU Le-lan
LIU Hong-ning
LYU Hong
XU Huan-jun
ZHU Xiao-cui
ZHANG Zhou-miao
FU Jian-jiang
ZENG Yifei
Related Institution
Beijing Hospital of Traditional Chinese Medicine,Capital Medical University
Beijing University of Chinese Medicine
Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine(TCM)
Tianjin University of TCM
The First Clinical Medical College of Anhui University of Chinese Medicine


